These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31913732)

  • 1. Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies).
    Varenhorst C; Hasvold P; Johansson S; Janzon M; Albertsson P; Leosdottir M; Hambraeus K; James S; Jernberg T; Svennblad B; Lagerqvist B
    J Am Heart Assoc; 2018 Jan; 7(1):e007174. PubMed ID: 31913732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
    Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
    J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
    Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial culprit-only versus initial multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry.
    Abe D; Sato A; Hoshi T; Takeyasu N; Misaki M; Hayashi M; Aonuma K
    Heart Vessels; 2014 Mar; 29(2):171-7. PubMed ID: 23529625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.
    Gyldenkerne C; Maeng M; Kjøller-Hansen L; Maehara A; Zhou Z; Ben-Yehuda O; Erik Bøtker H; Engstrøm T; Matsumura M; Mintz GS; Fröbert O; Persson J; Wiseth R; Larsen AI; Jensen LO; Nordrehaug JE; Bleie Ø; Omerovic E; Held C; James SK; Ali ZA; Rosen HC; Stone GW; Erlinge D
    Circulation; 2023 Feb; 147(6):469-481. PubMed ID: 36524476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonculprit lesion progression in patients with ST elevation myocardial infarction after primary percutaneous coronary intervention.
    Wang J; Liu JH; Zhu XL; Zhang M; Wang SP; Zheng Z
    Int Heart J; 2014; 55(1):48-52. PubMed ID: 24463926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events.
    Bae JH; Corban MT; Seo YH; Kim T; Lee G; Kwon TG; Kim KH; Song IG; Lee MS; Rihal CS; Lerman A
    Int J Cardiol; 2020 Jan; 299():26-30. PubMed ID: 31281049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonculprit Lesion Plaque Morphology in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography Substudys.
    Pinilla-Echeverri N; Mehta SR; Wang J; Lavi S; Schampaert E; Cantor WJ; Bainey KR; Welsh RC; Kassam S; Mehran R; Storey RF; Nguyen H; Meeks B; Wood DA; Cairns JA; Sheth T
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008768. PubMed ID: 32646305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial.
    Wester A; Attar R; Mohammad MA; Andell P; Hofmann R; Jensen J; Szummer K; Erlinge D; Koul S
    J Am Heart Assoc; 2019 Aug; 8(16):e012741. PubMed ID: 31387441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culprit-Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial-Extracorporeal Membrane Oxygenation.
    Choi KH; Yang JH; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Ahn CM; Yu CW; Park IH; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Kang TS; Gwon HC
    J Am Heart Assoc; 2023 May; 12(10):e029792. PubMed ID: 37158104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.
    Sheth T; Pinilla-Echeverri N; Moreno R; Wang J; Wood DA; Storey RF; Mehran R; Bainey KR; Bossard M; Bangalore S; Schwalm JD; Velianou JL; Valettas N; Sibbald M; Rodés-Cabau J; Ducas J; Cohen EA; Bagai A; Rinfret S; Newby DE; Feldman L; Laster SB; Lang IM; Mills JD; Cairns JA; Mehta SR
    J Am Coll Cardiol; 2020 Sep; 76(11):1277-1286. PubMed ID: 32912441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
    Sabatine MS; De Ferrari GM; Giugliano RP; Huber K; Lewis BS; Ferreira J; Kuder JF; Murphy SA; Wiviott SD; Kurtz CE; Honarpour N; Keech AC; Sever PS; Pedersen TR
    Circulation; 2018 Aug; 138(8):756-766. PubMed ID: 29626068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction.
    James S; Koul S; Andersson J; Angerås O; Bhiladvala P; Calais F; Danielewicz M; Fröbert O; Grimfjärd P; Götberg M; Henareh L; Ioanes D; Jensen J; Linder R; Lindroos P; Omerovic E; Panayi G; Råmunddal T; Sarno G; Ulvenstam A; Völtz S; Wagner H; Wikström H; Östlund O; Erlinge D
    Circ Cardiovasc Interv; 2021 Dec; 14(12):e008969. PubMed ID: 34903034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of healed coronary plaque in non-culprit lesions assessed by optical coherence tomography.
    Usui E; Mintz GS; Lee T; Matsumura M; Zhang Y; Hada M; Yamaguchi M; Hoshino M; Kanaji Y; Sugiyama T; Murai T; Yonetsu T; Kakuta T; Maehara A
    Atherosclerosis; 2020 Sep; 309():1-7. PubMed ID: 32836017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia From Nonculprit Stenoses Is Not Associated With Reduced Culprit Infarct Size in Patients with ST-Segment-Elevation Myocardial Infarction.
    Ekström K; Nielsen JVW; Nepper-Christensen L; Ahtarovski KA; Kyhl K; Göransson C; Bertelsen L; Ghotbi AA; Kelbæk H; Høfsten DE; Køber L; Schoos MM; Vejlstrup N; Lønborg J; Engstrøm T
    Circ Cardiovasc Imaging; 2021 May; 14(5):e012290. PubMed ID: 33951923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study.
    Dohi T; Maehara A; Witzenbichler B; Rinaldi MJ; Mazzaferri EL; Duffy PL; Weisz G; Neumann FJ; Henry TD; Cox DA; Stuckey TD; Brodie BR; Litherland C; Brener SJ; Kirtane AJ; Mintz GS; Stone GW
    Circ Cardiovasc Interv; 2015 Dec; 8(12):e002447. PubMed ID: 26643737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.